Before you read this and become incensed, first realize that all of the evidence is not in yet.
Second, this is not license to do nothing or encouraging you to do nothing.
The studies on boosting glutathione indicate that the supplements that potentate glutathione production may be a viable and much safer option.
There are scientific studies that show ways to reduce the risks of seasonal flu. One of the safest ways is by boosting your intercellular glutathione. There are numerous products that can do this, but in the spirit of this report, there is only one that actually has legitimate scientific evidence that it does.
It is a bonded whey protein isolate. The other products claim that they do, and they may, but there is no high level scientific proof, unfortunately. If anyone claims that their product does, ask to see the study. Then look and see if it is actually published in any peer reviewed journal or, if like Tamiflu, it has somehow disappeared.
The British Medical Journal report on the Cochrane review: Tamiflu use in adults with influenza.
A pediatrician from Japan, Keiji Hayashi, commented that his team attempted to verify the data (used to say Tamiflu is effective), but …found a series of inconsistencies in the evidence for (Tamiflu’s) effectiveness and safety.
In updating their Cochrane review, noted that there was a failure to verify claims or provide the analysis of drug company trials.
The claims are that Tamiflu reduces the risk of complications in healthy adults with influenza. These claims are an important part of the decisions to stockpile the drug and make it widely available.
The conclusion…
“Conclusion Neuraminidase inhibitors have modest effectiveness against the symptoms of influenza in otherwise healthy adults. The drugs are effective postexposure against laboratory confirmed influenza, but this is a small component of influenza-like illness, so for this outcome neuraminidase inhibitors are not effective. Neuraminidase inhibitors might be regarded as optional for reducing the symptoms of seasonal influenza. Paucity of good data has undermined previous findings for oseltamivir’s prevention of complications from influenza. Independent randomized trials to resolve these uncertainties are needed.”
Why don’t we have all the evidence on oseltamivir? is another article on the BJM website.
“The review and a linked investigation undertaken jointly by the BMJ and Channel 4 News2 cast doubt not only on the effectiveness and safety of oseltamivir (Tamiflu) but on the system by which drugs are evaluated, regulated, and promoted.”
With stories like this, who needs soap operas. Did someone say to dump the pharm stock before this hits the fan. Sorry but this is not anything new. From family friendly Disney to Xerox, all big corporations have been naughty from time to time. They get a multi-million dollar fine slap on the hands and then are off to do it again.
Good health to you, yours and, at least in this case, your pocket book.
For the conspiracy theorist out there, how does this stack up against the new FDA rules on Websites and Blogs? I am not an attorney, only a legal nurse consultant. But, based on what little I know, they are in the clear because of the wording on the website. Any thoughts?